ISPC VS BIMI Stock Comparison

Performance

ISPC
10/100

ISPC returned -65.85% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

BIMI
10/100

BIMI returned -55.97% in the last 12 months. Based on SPY's performance of -11.83%, its performance is below average giving it a score of 10 of 100.

Sentiment

ISPC
61/100

ISPC had a bullish sentiment score of 61.25% across Twitter and StockTwits over the last 12 months. It had an average of 1.00 posts, 0.00 comments, and 0.00 likes per day.

BIMI

"Sentiment" not found for BIMI

Technicals

ISPC
21/100

ISPC receives a 21 of 100 based on 14 indicators. 2 are bullish, 10 are bearish.

BIMI
11/100

BIMI receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

ISPC
10/100

ISPC has missed earnings 7 times in the last 20 quarters.

BIMI

"Earnings" not found for BIMI

Profit

ISPC
10/100

Out of the last 17 quarters, ISPC has had 0 profitable quarters and has increased their profits year over year on 0 of them.

BIMI
10/100

Out of the last 20 quarters, BIMI has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

ISPC
53/100

ISPC has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.

BIMI
42/100

BIMI has had a lower than average amount of volatility over the last 12 months giving it a score of 42 of 100.

All score calculations are broken down here to help you make more informed investing decisions

iSpecimen Inc. Common Stock Summary

Nasdaq / ISPC

Healthcare

Medical - Diagnostics & Research

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

BIMI International Medical Inc. Common Stock Summary

Nasdaq / BIMI

Healthcare

Medical - Pharmaceuticals

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

Power up your portfolio